HD group | non-HD group | p-value | |
---|---|---|---|
AKSS-knee score at the two year follow-up | 95.0 ± 9.8 (72–100) | 96.8 ± 5.5 (69–100) | 0.4641 |
Pain | 48.1 ± 6.0 (30–50) | 49.2 ± 2.8 (30–50) | 0.7978 |
Total range of flexion | 23.8 ± 3.6 (12–25) | 24.2 ± 1.9 (14–25) | 0.3893 |
Stability | 25.0 ± 0.0 (25–25) | 25.0 ± 0.0 (25–25) | 1.0000 |
Flexion contracture | 1.2 ± 3.3 (0–15) | 0.5 ± 0.9 (0–2) | 0.7817 |
Extension lag | 0.7 ± 1.8 (0–5) | 0.5 ± 2.7 (0–20) | 0.1175 |
Alignment | 0.0 ± 0.0(0–0) | 0.5 ± 2.3 (0–15) | 0.2653 |
Increase from preoperative score | 50.1 ± 19.3 (26–90) | 50.2 ± 17.1 (14–91) | 0.8633 |
AKSS-function score at the two year follow-up | 73.1 ± 27.2 (0–100) | 78.9 ± 18.8 (15–100) | 0.6314 |
Walking | 41.4 ± 14.2 (0–50) | 45.8 ± 7.9 (20–50) | 0.2368 |
Stairs | 33.3 ± 12.8 (0–50) | 36.0 ± 10.8 (0–50) | 0.6052 |
Walking aids used | 2.1 ± 4.6 (0–20) | 3.0 ± 4.9 (0–20) | 0.2639 |
Increase from preoperative score | 42.4 ± 29.7 (− 35–90) | 45.9 ± 20.6 (− 20–90) | 0.8923 |
AKSS-knee score at the last follow-up | 95.4 ± 7.7 (72–100) | 97.6 ± 3.4 (83–100) | 0.9048 |
Pain | 48.8 ± 3.1 (40–50) | 49.3 ± 1.8 (45–50) | 0.8595 |
Total range of flexion | 23.5 ± 3.6(12–25) | 24.2 ± 2.4 (8–25) | 0.8083 |
Stability | 24.5 ± 1.5 (20–25) | 25.0 ± 0.0 (25–25) | 0.0089 |
Flexion contracture | 1.2 ± 3.3 (0–15) | 0.5 ± 1.0 (0–5) | 0.6166 |
Extension lag | 0.2 ± 1.1 (0–5) | 0.07 ± 0.6 (0–5) | 0.3572 |
Alignment | 0.0 ± 0.0(0–0) | 0.3 ± 1.5 (0–9) | 0.3409 |
Increase from preoperative score | 50.5 ± 18.5 (27–90) | 51.0 ± 16.7 (20–98) | 0.7979 |
AKSS-function score at the last follow-up | 66.9 ± 33.0 (0–100) | 79.2 ± 18.2(15–100) | 0.2674 |
Walking | 38.6 ± 16.5 (0–50) | 46.1 ± 7.7 (20–50) | 0.0330 |
Stairs | 30.0 ± 16.1 (0–50) | 36.1 ± 9.9 (0–50) | 0.3110 |
Walking aids used | 2.1 ± 4.6 (0–20) | 3.0 ± 4.6 (0–20) | 0.2640 |
Increase from preoperative score | 36.2 ± 34.3 (− 35–90) | 46.1 ± 20.0 (10–85) | 0.3269 |
Postoperative length of stay (days) | 25.4 ± 30.8 (9–154) | 17.2 ± 3.4 (12–32) | 0.4968 |
Postoperative follow-up period (months) | 42.2 ± 25.2 (24–98) | 62.7 ± 30.4 (25–150) | 0.0047 |
Operating time (minutes) | 83.8 ± 14.5 (64–109) | 80.4 ± 20.6 (46–139) | 0.2391 |
Anesthesia time (minutes) | 120.3 ± 17.3 (90–155) | 117.8 ± 28.1 (67–214) | 0.3473 |
Hemoglobin count on the first postoperative day (g/dL) | 10.4 ± 1.5 (7.8–13.2) | 10.1 ± 1.2 (7.2–13.2) | 0.4453 |
Hemoglobin count at one week postoperation (g/dL) | 9.3 ± 1.2 (7–11.2) | 9.7 ± 1.3 (6.8–14.1) | 0.3147 |
Platelet count on the first postoperative day (× 109/L) | 18.2 ± 6.1 (8.4–31.3) | 17.9 ± 6.8 (5.3–34.0) | 0.8269 |
Platelet count at one week postoperation (× 109/L) | 23.2 ± 7.0 (9.1–38.1) | 25.2 ± 8.6 (3.0–50.2) | 0.2764 |
Volume of allogenic blood transfusion (mL) | 1.1 ± 3.2 (0–14) | 0.08 ± 0.5 (0–4) | 0.0077 |